The Laboratory of Molecular Neuropsychiatry, led by Joseph D. Buxbaum, PhD, studies human psychiatric and neurological diseases using methods of cell biology, molecular biology, genetics, genomics, and animal models. Currently, we are focusing on autism spectrum disorder (ASD), Alzheimer’s disease, and schizophrenia.
The ASD research group within the Laboratory of Molecular Neuropsychiatry is part of the Seaver Autism Center, directed by Dr. Buxbaum. The Seaver Autism Center conducts progressive research studies aimed at understanding the multiple causes of ASD. The multidisciplinary team is comprised of experts in the fields of genetics, molecular biology, model systems, neuroimaging, and experimental therapeutics who are dedicated to discovering the biological causes of ASD. The Center strives to develop innovative diagnostics and treatments for integration into the provision of personalized, comprehensive assessment and care for people with ASD.
The Laboratory of Molecular Neuropsychiatry is affiliated with a number of institutes and departments within the Icahn School of Medicine at Mount Sinai.